Patient Preferences and Health State Utilities Associated with Mealtime Insulin Concentrations Among Patients with Diabetes in Italy

INTRODUCTION: Standard concentration (100 units/mL) mealtime insulin is frequently used to treat patients with type 1 (T1D) and type 2 diabetes (T2D). A more concentrated version of the medication (200 units/mL) has been available in Italy since 2016. This concentrated version is bioequivalent to th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Diabetes Ther
Päätekijät: Matza, Louis S., Osumili, Beatrice, Stewart, Katie D., Perez-Nieves, Magaly, Jordan, Jessica, Biricolti, Giovanni, Romoli, Ester, Losi, Serena, Del Santo, Silvia, Spaepen, Erik, Parola, Gordon, Karn, Hayley, Boye, Kristina S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Healthcare 2019
Aiheet:
Brief Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6965595/
https://ncbi.nlm.nih.gov/pubmed/31760598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-019-00718-8
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia